glp 1 and diabetic retinopathy Glucagon-like peptide-1 receptor agonists rescued vascular endothelial damage through suppression of aberrant STING signaling Frontiers | Unlocking the potential
Description
Type 2 diabetes mellitus (T2DM) is a major risk factor for cardiovascular disease
While GLP-1 agonist therapy medications have been marketed as diabetes treatments before, Mounjaro also has the action of glucose-dependent insulinotropic polypeptide (GIP)
this supports the hypothesis that the cardioprotective benefits of GLP-1RA and SGLT2i may be additive
Your existing OSD line can't make it as-is
Also, the drug needs to be taken on an empty stomach immediately on waking, with no more than 120 mL of water
Check out Ro's 30 second TV commercial, 'GLP-1: Monthly Pen'
